Hemispherx Biopharma Inc (NYSE American:HEB)

0.3089
Delayed Data
As of 10:47am ET
 +0.0022 / +0.72%
Today’s Change
0.28
Today|||52-Week Range
0.74
-10.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash2.2M2.1M2.4M1.4M
 
 
 
 
 
Short Term Investment Cash1.4M-41.0K293.0K-996.0K
 
 
 
 
 
Cash & Short Term Investments16.1M8.9M5.9M2.1M
 
 
 
 
 
 
ReceivablesReceivables--0.000.0024.0K
 
 
 
InventoriesInventories--1.3M0.000.00
 
 
 
Current AssetsOther Current Assets399.0K335.0K1.1M1.4M
 
 
 
 
 
Current Assets16.5M10.6M6.9M3.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross16.9M17.2M16.2M16.2M
 
 
 
 
 
Depreciation-5.0M-5.9M-6.6M-7.6M
 
 
 
 
 
Intangible Assets861.0K862.0K872.0K858.0K
 
 
 
 
 
Other Assets995.0K996.0K2.4M2.1M
 
 
 
 
 
Total Assets29.4M22.8M18.9M14.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.1M1.2M887.0K741.0K
 
 
 
 
 
Short Term Debt22.0K1.0K0.000.00
 
 
 
Accrued Expenses527.0K990.0K1.3M1.4M
 
 
 
 
 
Other Current Liabilities527.0K990.0K1.3M1.4M
 
 
 
 
 
Other Liabilities4.4M2.4M2.4M2.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.000.001.8M
 
 
Other Liabilities0.000.00940.0K0.00
 
 
Total Liabilities4.4M2.4M3.4M4.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity25.0M20.4M15.5M8.7M
 
 
 
 
 
Total Shareholder Equity25.0M20.4M15.5M8.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding17.0M20.6M24.2M32.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.